Breast lumps differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 667: | Line 667: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 686: | Line 686: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 705: | Line 705: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 721: | Line 721: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Fat necrosis | ! align="center" style="background:#DCDCDC;" |Fat necrosis<ref name="pmid9423681">{{cite journal| author=Soo MS, Kornguth PJ, Hertzberg BS| title=Fat necrosis in the breast: sonographic features. | journal=Radiology | year= 1998 | volume= 206 | issue= 1 | pages= 261-9 | pmid=9423681 | doi=10.1148/radiology.206.1.9423681 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9423681 }}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Breast trauma | * Breast trauma | ||
* Surgical intervention | * Surgical intervention | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |Common among women | ||
| align="center" style="background:#F5F5F5;" | | |||
May mimic malignancy features | |||
| align="center" style="background:#F5F5F5;" |Benign breast lumps develop after trauma/ surgery | |||
Suspicious lumps required biopsy | |||
No excision in established diagnosis | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |± | |||
| align="center" style="background:#F5F5F5;" |– | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Hard or smooth mass | |||
* Solitary mass | |||
* Mobile | |||
| align="center" style="background:#F5F5F5;" |– | |||
| align="center" style="background:#F5F5F5;" |– | |||
| align="center" style="background:#F5F5F5;" |NA | |||
| align="center" style="background:#F5F5F5;" |Nl | |||
| align="center" style="background:#F5F5F5;" |Collections of liquefied fat | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Collections of liquefied fat | |||
* Oil cysts | |||
| align="center" style="background:#F5F5F5;" | Ultrasound | | align="center" style="background:#F5F5F5;" | Ultrasound | ||
| align="center" style="background:#F5F5F5;" | NA | | align="center" style="background:#F5F5F5;" | NA |
Revision as of 16:32, 18 January 2019
Breast lumps Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Breast lumps differential diagnosis On the Web |
American Roentgen Ray Society Images of Breast lumps differential diagnosis |
Risk calculators and risk factors for Breast lumps differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
Breast lumps must be differentiated from other diseases such as malignancy, cysts, inflammation and non-inflammatory solid lumps. Breast symptoms such as nipple discharge and mastalgia require assessment as well.
Differentiating Breast lumps from other Diseases
Differential diagnosis of breast lumps include:
Diseases | Etiology | Benign | Malignant | Clinical manifestation | Paraclinical findings | Gold standard diagnosis | Associated findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | Lab findings | Histopathology | Imaging | ||||||||||||
Mass | Mastalgia | Nipple discharge | Breast exam | Skin changes | LAP | Others | ||||||||||||
Fibroadenoma[1] |
|
+ |
|
|
|
+ | ± | – |
|
– | – | NA | Nl | Proliferative breast lesion without atypia | Well-defined, solid mass | Mammography or ultrasound + biopsy | NA | |
Breast cyst[2] |
|
+ |
|
|
|
+ | ± | – |
|
– | – | NA | Nl |
|
|
|
NA | |
Fibrocystic change[3] |
|
+ |
|
|
|
+ | + | ± |
|
– | – | NA | Nl | Nonproliferative breast lesions |
|
|
NA | |
Galactocele[4] | Milk duct obstruction | + | No increased risk of malignancy |
|
|
+ | ± | ± |
|
– | – | NA | Nl | Nonproliferative breast lesions |
|
|
NA | |
Cysts of montgomery[5] | Obstruction of periareolar glands of montgomery | + | No increased risk of malignancy | Most common in age of 10-20 years old |
|
+ | ± | ± |
|
± | – | NA | Nl | Nonproliferative breast lesions | Single cystic lesion in retroareolar area | Ultrasound | NA | |
Hamartoma[6] | Unknown | + | Coexisting malignancy can occur | Common in women older than 35 years old |
|
± | – | – |
|
± | – | NA | Nl | Nonproliferative breast lesions |
|
|
NA | |
Breast abscess[7] | Complication of breast mastitis | + | No increased risk of malignancy |
|
Resolve after drainage/
anti-biotic therapy |
+ | + | – |
|
+ | – |
|
Blood culture is required in severe infection | Nonproliferative breast lesions | Fluid collection | Ultrasound | NA | |
Mastitis[8][9] |
|
+ | No increased risk of malignancy |
|
Resolve after anti-biotic therapy/
drainage |
± | + | ± | Breast tenderness
Swollen breast tissue |
+ | – |
|
Leukocytosis | Nonproliferative breast lesions |
|
Ultrasound | NA | |
Diseases | Etiology | Benign | Malignant | Demography | History | Mass | Pain | Nipple discharge | Breast exam | Skin changes | LAP | Others | Lab findings | Histopathology | Imaging | Gold standard diagnosis | Associated findings | |
Breast carcinoma[10][11][12] |
|
– | + |
|
Positive family history | + | – | ± | Hard, immobile, solitary, and irregular margin | ± | ± | Breast size changes
Nipple abnormality |
Nl |
|
|
|
| |
Ductal carcinoma in situ (DCIS)[13][14] |
|
– | + |
|
|
± | – | ± | May have normal physical exam | – | – | NA | Nl |
|
Suspicious microclacifications | Mammography | Na | |
Microinvasive breast cancer[15] | Unknown |
– |
+ |
|
|
+ | – | ± |
|
– | ± | NA | Nl | Associated with high grade DCIS |
|
Mammography | NA | |
Breast sarcoma[16] |
|
– | + |
|
|
+ | – | – | Well-defined, firm mass | ± | – | NA | Nl |
|
|
Mammography | NA | |
Phyllodes tumor[17][18] | Unknown | ± | ± | Most common in premenopausal women (40-50 years) |
|
± | – | – |
|
– | – | NA | Nl | Nonepithelial breast neoplasm with average size of 5 cm |
|
|
NA | |
Lymphoma[19][20] | Non-Hodgkin lymphoma | – | + |
|
|
+ | – | – |
|
– | ± | NA | Nl |
Diffuse B cell lymphomas |
|
|
NA | |
Duct ectasia[21] | Unknown | + | – | Common among perimenopausal women | Usually resolve spontaneously | ± | ± | ± | Usually asymptomatic | – | – | NA | Nl | Distention of subareolar ducts |
|
|
NA | |
Intraductal papilloma[22] | Unknown | + | – | Common in women between 35-55 years old |
|
+ | ± | ± |
|
– | – | NA | Nl | Growth of papillary cell into a lumen |
|
Core needle biopsy | NA | |
Lipoma[23] | Unknown | + | – | Common between age of 40-60 years old |
|
+ | – | – |
|
– | – | NA | Nl | Solitary tumor of mature fat cells |
|
|
NA | |
Sclerosing adenosis[24][25] | Unknown | + | Small risk of malignancy | Result in repeating pain during mensturation |
|
± | + | – |
|
± | – | NA | Nl |
|
|
|
NA | |
Pseudoangiomatous stromal hyperplasia[26][27] | Unknown | + | – | Common in reproductive age women |
|
+ | – | – |
|
– | – | NA | Nl |
|
|
|
NA | |
Mondor's disease[28][29] | Complication of:
|
+ | – |
|
|
+ | + | – | Thick and tender cord on breast skin | + | – | NA | Nl | Thrombophlebitis of superficial veins of the breast |
|
|
NA | |
Diseases | Etiology | Benign | Malignant | Demography | History | Mass | Pain | Nipple discharge | Breast exam | Skin changes | LAP | Others | Lab findings | Histopathology | Imaging | Gold standard diagnosis | Associated findings | |
Neurofibroma | + | – | ||||||||||||||||
Gynecomastia | + | – | ||||||||||||||||
Breast trauma | + | – | ||||||||||||||||
Fat necrosis[30] |
|
+ | – | Common among women
May mimic malignancy features |
Benign breast lumps develop after trauma/ surgery
Suspicious lumps required biopsy No excision in established diagnosis |
+ | ± | – |
|
– | – | NA | Nl | Collections of liquefied fat |
|
Ultrasound | NA |
References
- ↑ Pinto, Joana; Aguiar, Ana Teresa; Duarte, Hálio; Vilaverde, Filipa; Rodrigues, Ângelo; Krug, José Luís (2014). "Simple and Complex Fibroadenomas". Journal of Ultrasound in Medicine. 33 (3): 415–419. doi:10.7863/ultra.33.3.415. ISSN 0278-4297.
- ↑ Courtillot C, Plu-Bureau G, Binart N, Balleyguier C, Sigal-Zafrani B, Goffin V; et al. (2005). "Benign breast diseases". J Mammary Gland Biol Neoplasia. 10 (4): 325–35. doi:10.1007/s10911-006-9006-4. PMID 16900392.
- ↑ Templeman C, Hertweck SP (2000). "Breast disorders in the pediatric and adolescent patient". Obstet Gynecol Clin North Am. 27 (1): 19–34. PMID 10693180.
- ↑ Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de las Heras P; et al. (2007). "Radiologic evaluation of breast disorders related to pregnancy and lactation". Radiographics. 27 Suppl 1: S101–24. doi:10.1148/rg.27si075505. PMID 18180221.
- ↑ De Silva NK, Brandt ML (2006). "Disorders of the breast in children and adolescents, Part 2: breast masses". J Pediatr Adolesc Gynecol. 19 (6): 415–8. doi:10.1016/j.jpag.2006.09.002. PMID 17174833.
- ↑ Tse GM, Law BK, Ma TK, Chan AB, Pang LM, Chu WC; et al. (2002). "Hamartoma of the breast: a clinicopathological review". J Clin Pathol. 55 (12): 951–4. PMC 1769817. PMID 12461066.
- ↑ Dixon JM (2007). "Breast abscess". Br J Hosp Med (Lond). 68 (6): 315–20. doi:10.12968/hmed.2007.68.6.23574. PMID 17639835.
- ↑ Dixon JM, Ravisekar O, Chetty U, Anderson TJ (1996). "Periductal mastitis and duct ectasia: different conditions with different aetiologies". Br J Surg. 83 (6): 820–2. PMID 8696751.
- ↑ Committee on Health Care for Underserved Women, American College of Obstetricians and Gynecologists (2007). "ACOG Committee Opinion No. 361: Breastfeeding: maternal and infant aspects". Obstet Gynecol. 109 (2 Pt 1): 479–80. PMID 17267864.
- ↑ Siegel RL, Miller KD, Jemal A (January 2018). "Cancer statistics, 2018". CA Cancer J Clin. 68 (1): 7–30. doi:10.3322/caac.21442. PMID 29313949.
- ↑ Li CI, Uribe DJ, Daling JR (October 2005). "Clinical characteristics of different histologic types of breast cancer". Br. J. Cancer. 93 (9): 1046–52. doi:10.1038/sj.bjc.6602787. PMC 2361680. PMID 16175185.
- ↑ Parise CA, Bauer KR, Brown MM, Caggiano V (2009). "Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004". Breast J. 15 (6): 593–602. doi:10.1111/j.1524-4741.2009.00822.x. PMID 19764994.
- ↑ Virnig BA, Tuttle TM, Shamliyan T, Kane RL (February 2010). "Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes". J. Natl. Cancer Inst. 102 (3): 170–8. doi:10.1093/jnci/djp482. PMID 20071685.
- ↑ Brinton LA, Sherman ME, Carreon JD, Anderson WF (November 2008). "Recent trends in breast cancer among younger women in the United States". J. Natl. Cancer Inst. 100 (22): 1643–8. doi:10.1093/jnci/djn344. PMC 2720764. PMID 19001605.
- ↑ Sue GR, Lannin DR, Killelea B, Chagpar AB (October 2013). "Predictors of microinvasion and its prognostic role in ductal carcinoma in situ". Am. J. Surg. 206 (4): 478–81. doi:10.1016/j.amjsurg.2013.01.039. PMID 23791403.
- ↑ Smith TB, Gilcrease MZ, Santiago L, Hunt KK, Yang WT (April 2012). "Imaging features of primary breast sarcoma". AJR Am J Roentgenol. 198 (4): W386–93. doi:10.2214/AJR.11.7341. PMID 22451578.
- ↑ Geisler DP, Boyle MJ, Malnar KF, McGee JM, Nolen MC, Fortner SM, Broughan TA (April 2000). "Phyllodes tumors of the breast: a review of 32 cases". Am Surg. 66 (4): 360–6. PMID 10776873.
- ↑ Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, Hunt KK (October 2000). "Primary treatment of cystosarcoma phyllodes of the breast". Cancer. 89 (7): 1502–11. PMID 11013364.
- ↑ Brogi E, Harris NL (June 1999). "Lymphomas of the breast: pathology and clinical behavior". Semin. Oncol. 26 (3): 357–64. PMID 10375092.
- ↑ Barişta I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozişik Y, Güler N, Güllü IH, Atahan IL, Firat D (2000). "Primary breast lymphomas--a retrospective analysis of twelve cases". Acta Oncol. 39 (2): 135–9. PMID 10859001.
- ↑ Schwartz GF (June 1982). "Benign neoplasms and "inflammations" of the breast". Clin Obstet Gynecol. 25 (2): 373–85. PMID 6286199.
- ↑ Wen X, Cheng W (January 2013). "Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors". Ann. Surg. Oncol. 20 (1): 94–101. doi:10.1245/s10434-012-2590-1. PMID 22878621.
- ↑ Guray M, Sahin AA (May 2006). "Benign breast diseases: classification, diagnosis, and management". Oncologist. 11 (5): 435–49. doi:10.1634/theoncologist.11-5-435. PMID 16720843.
- ↑ Jensen RA, Page DL, Dupont WD, Rogers LW (1989). "Invasive breast cancer risk in women with sclerosing adenosis". Cancer. 64 (10): 1977–83. PMID 2804888.
- ↑ Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N (2004). "Lower-category benign breast disease and the risk of invasive breast cancer". J Natl Cancer Inst. 96 (8): 616–20. PMID 15100339.
- ↑ Celliers L, Wong DD, Bourke A (2010). "Pseudoangiomatous stromal hyperplasia: a study of the mammographic and sonographic features". Clin Radiol. 65 (2): 145–9. doi:10.1016/j.crad.2009.10.003. PMID 20103437.
- ↑ Salvador R, Lirola JL, Domínguez R, López M, Risueño N (2004). "Pseudo-angiomatous stromal hyperplasia presenting as a breast mass: imaging findings in three patients". Breast. 13 (5): 431–5. doi:10.1016/j.breast.2003.10.011. PMID 15454202.
- ↑ Becker L, McCurdy LI, Taves DH (2001). "Superficial thrombophlebitis of the breast (Mondor's disease)". Can Assoc Radiol J. 52 (3): 193–5. PMID 11436415.
- ↑ Catania S, Zurrida S, Veronesi P, Galimberti V, Bono A, Pluchinotta A (1992). "Mondor's disease and breast cancer". Cancer. 69 (9): 2267–70. PMID 1562972.
- ↑ Soo MS, Kornguth PJ, Hertzberg BS (1998). "Fat necrosis in the breast: sonographic features". Radiology. 206 (1): 261–9. doi:10.1148/radiology.206.1.9423681. PMID 9423681.